Dystonia Clinical Trial
Official title:
Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients With Focal Hand Dystonia
This study will evaluate the effect of transcranial electrical polarization (TEP), also
called direct current (DC) stimulation, on focal hand dystonia in people with writer's cramp.
In dystonia, muscle spasms cause uncontrolled twisting and repetitive movement or abnormal
postures. Focal dystonia involves just one part of the body, such as the hand, neck or face.
When people with focal hand dystonia make small and repeated movements with their hands,
there is extra activity in the part of the brain called the motor cortex. TEP is a method of
brain stimulation that slows down the activity of the nerve cells in the motor cortex. This
study may help researchers develop new ways to treat focal hand dystonia.
People 18 years of age and older with focal hand dystonia may be eligible for this study.
Participants have a neurological examination and are randomly assigned to one of two
treatment groups: TEP or placebo stimulation. The TEP group receives stimulation to the parts
of the brain used for hand movement, and the placebo group receives sham stimulation, which
does not affect any area of the brain. There are three TEP/placebo sessions over a period of
7 to 10 days. The first session may last up to 2-1/2 hours; the other two sessions last 1-2
hours.
For TEP, sponge electrodes are placed on the scalp and an electrical current is passed
through the scalp and skull to the outer part of brain. Before and after each session,
participants have a neurological examination, including an evaluation of the rate and
severity of their movement problems. For this assessment, participants do a writing test
while the electrical activity of their hand muscles is recorded using surface
electromyography (EMG). For EMG, small metal disks (electrodes) filled with a conductive gel
are taped to the skin over the muscles being tested.
Patients are followed in the clinic the day after the end of TEP treatment for evaluation of
their movement abilities and the effects of therapy, such as improvement of handwriting.
Objective: The treatment of focal hand dystonia (FHD) needs further improvement. A deficiency
of inhibition was demonstrated in patients with writer's cramp. The passage of weak DC
currents across the head, or transcranial electrical polarization (TEP) has been done for
many years with numerous effects described in healthy subjects and mentally diseased
patients. Recently, it has been shown by objective means, in controlled experiments, that
this type of treatment has robust and lasting effects on the excitability of the motor cortex
in healthy humans.
Study population: 40 subjects with focal hand dystonia.
Design: We hypothesize that TEP will have a beneficial effect on hand writing in patients
with FHD because it will decrease the excitability of the motor cortex compensating the
deficiency of inhibition. Specifically, we propose to look at the effect of 2 mA TEP with
cathode position over the hand projection in the contralateral to the affected hand primary
motor cortex. Anodes will be placed over the orbit and mastoid process ipsilateral to the
affected hand (contralateral to the cathode). Over a two-year period, we will enroll 40
patients with FHD and evaluate the acute TEP effects over a period of 1 week (3 TEP
sessions).
Outcome measures: Symptoms will be evaluated by kinematic analysis of the handwriting and
with dystonia scales.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01433757 -
Ampicillin for DYT-1 Dystonia Motor Symptoms
|
Phase 1 | |
Recruiting |
NCT00971854 -
Alteration of Deep Brain Stimulation Parameters for Dystonia
|
N/A | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00169338 -
Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia
|
Phase 2 | |
Completed |
NCT00004421 -
Deep Brain Stimulation in Treating Patients With Dystonia
|
Phase 2/Phase 3 | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Recruiting |
NCT02583074 -
Clinical Trial of STN-DBS for Primary Cranial-Cervical Dystonia
|
N/A | |
Recruiting |
NCT06117020 -
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
|
Phase 1 | |
Completed |
NCT01432899 -
Studying Childhood-Onset Hemidystonia
|
||
Completed |
NCT04948684 -
Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism
|
||
Completed |
NCT05106816 -
The Effects of Vibrotactile Stimulation in Patients With Movement Disorders
|
N/A | |
Recruiting |
NCT05027997 -
Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm
|
Phase 2 | |
Completed |
NCT00465790 -
Research of Biomarkers in Parkinson Disease
|
Phase 0 | |
Active, not recruiting |
NCT00142259 -
Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia
|
Phase 4 | |
Recruiting |
NCT05663840 -
Effects of Exercise on Dystonia Pathophysiology
|
N/A | |
Not yet recruiting |
NCT06038097 -
Efficacy and Safety of Radiofrequency Pallidotomy in the Management of Dystonia
|
N/A | |
Recruiting |
NCT04286308 -
Cortical-Basal Ganglia Speech Networks
|
N/A | |
Active, not recruiting |
NCT03582891 -
The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy
|
N/A | |
Completed |
NCT03318120 -
Exercise Training in Dystonia
|
N/A | |
Completed |
NCT04568681 -
Deep Brain Stimulation Effects in Dystonia
|